Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-004393
Filing Date
2021-04-22
Accepted
2021-04-22 16:44:44
Documents
1
Period of Report
2021-04-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-52317.html 4  
1 PRIMARY DOCUMENT marketforms-52317.xml 4 3964
  Complete submission text file 0001214659-21-004393.txt   5441
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address
Kilcoyne Adrian (Reporting) CIK: 0001857963 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 21845358